Recent studies have shown that STAT3 is abnormally and continuously activated in leukaemia, lung cancer, liver cancer, breast cancer and prostate cancer, and that constitutive activation of the STAT3 signalling pathway promotes malignant proliferation and invasion of cells, leading to tumorigenesis and tumour progression.41 Here, STAT3 is linked to prostate carcinoma.